MACSYS Seminar: Dr David S. Wishart

MACSYS Seminar: Dr David S. Wishart

MACSYS Seminar: Dr David S. Wishart

49 49 people viewed this event.

25 Years of Cellular Modelling: A Personal Journey

MACSYS is honoured to present Dr David S Wishart from the University of Alberta (Canada).  Dr Wishart is a key innovator in bioinformatics, metabolomics, and exposomics.

Register for a zoom link

Abstract: In 2001, I began using cellular automata to model Escherichia coli through a little-known effort called the CyberCell project. The ambition was to simulate a living cell; the obstacle was knowing what was inside it. Existing measurements and modelling systems could not adequately quantify or represent metabolite and protein concentrations. Frustrated, I set aside cellular modelling and began building the quantitative foundations it required. This detour led me to develop quantitative metabolomics techniques aimed at compiling metabolite concentrations and pathway information across cells, tissues and organisms.

These efforts led to the development of resources such as the CyberCell Database, the HMDB, YMDB and ECMDB. However, even then, I found that existing pathway descriptions, connecting proteins to metabolites, remained insufficiently specific and difficult for computers to interpret. I therefore turned to constructing PathBank, the world’s largest pathway database, designed to make biological pathways more comprehensive, structured and machine readable. Thanks to AI and LLMs my lab has been able to accelerate this work. We have developed tools to automatically discover, extract and draw machine-readable pathways from the literature, continuously enrich our metabolome databases, predict metabolic reactions and products and use these resources to develop genome-to-metabolome prediction tools.

In this talk, I will trace how this 25-year effort to fix biology’s data problems brought me back to my original ambition. With richer quantitative data and unprecedented computing power, I believe predictive, quantitative whole-cell modelling is finally becoming a realistic undertaking.

Our Speaker: Dr. David S. Wishart, Distinguished University Professor, University of Alberta

David Wishart earned his PhD in Molecular Biophysics from Yale University in 1991 and joined the University of Alberta as an assistant professor in 1995, becoming a full professor in 2003. He is currently a Distinguished University Professor in the Departments of Biological Sciences and Computing Science, with adjunct appointments in the Faculty of Pharmacy and Pharmaceutical Sciences and the Department of Laboratory Medicine and Pathology. He holds a Tier 1 Canada Research Chair in Metabolomics and Precision Medicine.

Wishart’s multidisciplinary research spans metabolomics, exposomics, precision medicine, precision nutrition, bioinformatics, cheminformatics, structural biology, artificial intelligence, robotics and analytical chemistry. His work has enabled the identification and quantification of metabolites in complex biological samples, the discovery of biomarkers for cancer, cardiovascular disease, neurological disorders, infectious disease, organ dysfunction and environmental exposure, and the development of computational tools for predicting molecular structures, properties, spectra, metabolic pathways and biological activities.

After pioneering computational approaches for interpreting NMR spectra of biofluids in 1999, Wishart helped establish metabolomics as a major scientific discipline. In 2005, he launched the Human Metabolome Project and subsequently created the Human Metabolome Database. His laboratory has developed more than 100 freely accessible databases and software tools, including HMDB, DrugBank, FooDB, MetaboAnalyst, CFM-ID, BioTransformer, PathBank and NP-MRD, which are used by millions of researchers worldwide. In 2011, he co-founded The Metabolomics Innovation Centre (TMIC), Canada’s national metabolomics laboratory, which now includes eight research nodes, employs more than 30 scientists and houses over $35 million in equipment. He has also helped launch more than a dozen biotechnology companies, including BioTools, Chenomx and Molecular You.

Wishart has authored or co-authored nearly 700 publications, received more than 166,000 citations and attained an h-index of 155. His honours include election to the Royal Society of Canada in 2017, appointment as Distinguished University Professor in 2018, the J. Gordin Kaplan Award in 2023, the NSERC Brockhouse Prize in 2024, the University Cup and NSERC Herzberg Gold Medal in 2025, and a Governor General’s Innovation Award in 2026.

Seminar Chair: Professor Malcolm McConville, MACSYS Chief Investigator

—————

Please note you must be registered for this event to receive the webinar link. The webinar link will be sent via calendar invite by the 24th November.

View the MACSYS Code of Conduct here https://macsys.org/about_macsys/code-of-conduct/

Media Notice: This webinar will be recorded in its entirety, including the video, audio, and presentation materials. The recording may be published publicly and used for future marketing and educational purposes. Privacy options for online attendees include keeping their camera and microphones turned off.

Any questions about this seminar please contact: MACSYS-Events@unimelb.edu.au

 

Date And Time

08-12-2026 @ 09:00 AM
 

Location

Online event
 

Event Types

Share With Friends

ARC Centre of Excellence for the Mathematical Analysis of Cellular Systems (MACSYS)

  • The University of Melbourne Victoria 3010 Australia
  • +61 3 8344 9188

© ARC Centre of Excellence for the Mathematical Analysis of Cellular Systems


The ARC Centre of Excellence for the Mathematical Analysis of Cellular Systems (MACSYS) acknowledges First Nations peoples as the first scientists, makers and innovators of this land and their continuing connection to Country. We pay our respects to all Aboriginal and Torres Strait Islander Peoples culture and to Elders past and present.

We pride ourselves in our commitment to foster and promote a diverse, safe and respectful environment free from discrimination, harassment, or victimisation based on individual identity and experience.

Privacy Preference Center